JB
FOMX

Julian Baker’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Julian Baker’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-498,189
Closed -$1.51M – 111
2019
Q3 		$1.51M Hold
498,189
– – 0.01% 91
2019
Q2 		$1.19M Hold
498,189
– – 0.01% 92
2019
Q1 		$1.87M Hold
498,189
– – 0.01% 82
2018
Q4 		$1.79M Sell
498,189
-189,886
-28% -$826K 0.01% 75
2018
Q3 		$3.94M Sell
688,075
-802,126
-54% -$4.59M 0.03% 76
2018
Q2 		$7.47M Sell
1,490,201
-108,790
-7% -$560K 0.06% 62
2018
Q1 		$8.2M Sell
1,598,991
-867,711
-35% -$5.22M 0.07% 64
2017
Q4 		$14.8M Hold
2,466,702
– – 0.13% 52
2017
Q3 		$13.7M Hold
2,466,702
– – 0.11% 47
2017
Q2 		$11.4M Hold
2,466,702
– – 0.1% 45
2017
Q1 		$12.2M Hold
2,466,702
– – 0.1% 45
2016
Q4 		$27.4M Hold
2,466,702
– – 0.27% 27
2016
Q3 		$22.8M Buy
2,466,702
+225,000
+10% +$1.88M 0.21% 29
2016
Q2 		$14.2M Hold
2,241,702
– – 0.15% 45
2016
Q1 		$14.6M Buy
2,241,702
+194,735
+10% +$1.26M 0.15% 43
2015
Q4 		$16.6M Hold
2,046,967
– – 0.14% 51
2015
Q3 		$15M Hold
2,046,967
– – 0.14% 51
2015
Q2 		$21M Buy
2,046,967
+225,000
+12% +$2.49M 0.18% 46
2015
Q1 		$16.9M Buy
1,821,967
+800,367
+78% +$7.16M 0.14% 47
2014
Q4 		$7.16M Hold
1,021,600
– – 0.07% 61
2014
Q3 		$5.57M Buy
+1,021,600
New +$5.87M 0.07% 59

Other funds holding FOMX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Julian Baker's FOMX Position: Q4 2019 in Review

Julian Baker sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2019, closing a stake of 498,189 shares — an estimated $1.51M sold.

Julian Baker first reported a position in FOMX in Q3 2014 and held it in 21 quarters. The position peaked at $27.4M in Q4 2016. 65 funds tracked by Wall St. Rank hold FOMX as of Q4 2019.

  • Julian Baker reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2019 after selling out during the quarter.
  • Julian Baker sold 498,189 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2019, an estimated $1.51M.
  • Julian Baker first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2014 and held it in 21 quarters.
  • Julian Baker's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $27.4M in Q4 2016.
  • 65 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2019.

Based on Baker Bros. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.